WO2007083320A2 - Conversion of aromatic diazonium salt to aryl hydrazine - Google Patents
Conversion of aromatic diazonium salt to aryl hydrazine Download PDFInfo
- Publication number
- WO2007083320A2 WO2007083320A2 PCT/IN2007/000011 IN2007000011W WO2007083320A2 WO 2007083320 A2 WO2007083320 A2 WO 2007083320A2 IN 2007000011 W IN2007000011 W IN 2007000011W WO 2007083320 A2 WO2007083320 A2 WO 2007083320A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aryl
- salt
- moles
- hydrazine
- water
- Prior art date
Links
- WKEMJKQOLOHJLZ-UHFFFAOYSA-N CN(C)CCc1c[nH]c2ccc(CS(N3CCCC3)(=O)=O)cc12 Chemical compound CN(C)CCc1c[nH]c2ccc(CS(N3CCCC3)(=O)=O)cc12 WKEMJKQOLOHJLZ-UHFFFAOYSA-N 0.000 description 1
- AMKVXSZCKVJAGH-UHFFFAOYSA-N CNS(CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1)(=O)=O Chemical compound CNS(CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1)(=O)=O AMKVXSZCKVJAGH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
Definitions
- the present invention relates to the conversion of aromatic diazonium salt into aryl hydrazine.
- the aryl hydrazine thus formed can be pharmacologically useful compounds in treating a variety of ailments
- a common structural feature in many anti-migraine compounds is the presence of a 5- substituted indole moiety.
- Compounds such as Rizatriptan, Zolmitriptan, Sumatriptan, Almotriptan, Naratriptan, Eletriptan and the like, have a moiety present in their structure.
- No.5,399,574 describes a method for preparing Zolmitriptan and related compounds wherein the conversion of diazonium salt to hydrazine derivative is carried out in presence of tin chloride in concentrated hydrochloric acid followed by Fisher Indole cyclisation to give the desired 5-substituted tryptan.
- U.S. Pat. No. 5,298,520 discloses similar procedure for the synthesis of different 5-substituted tryptamines wherein the use of tin chloride is reported in presence of aqueous hydrochloric acid for the conversion of aromatic diazonium salt to hydrazine derivatives.
- 5,567,819 and 6,084,103 also describes a process for the preparation of the Rizatriptan and related molecules wherein the conversion of aryl hydrozonium salt to hydrazine is carried out with sodium sulphite in highly acidic medium. All the above processes require tin chloride as a reducing agent which is not easy to remove from the reaction mixture and is required more equivalents for reaction completion. The above processes make the finished product expensive. Isolation of the product from such reaction mixture is tedious, requires several critical layer separations, multi step column chromatography which ultimately gives low yield of the product.
- the present invention is provided a process for the conversion of an aryl diazonium salt of formula- II wherein R is selected from A,B,C,D,F and their substituted derivatives to aryl hydrazine of formula - III,
- R is defined as above and X is a salt or a protecting group with triphenyl phosphine in presence of an organic solvents.
- R is a designated residual of formula- A, which comprises reacting in-situ intermediate of formula - II with triphenyl phosphine in methanol followed by fisher indole cyclization with N,N,dimethyl amino acetal to get Zolmitriptan isomers, substituted derivative or salt thereof.
- aryl hydrazines of Formula -III wherein R and X are defined as above are being prepared by
- the present invention provides a process for the preparation of aryl hydrazines, which involves
- Triphenyl phosphine reacts with diazonium salt results a red color intermediate in a very good yield of triphenyl-aryl hydrazyl phosphonium salt, which practically disintegrate with the acidic hydrolysis quantitatively yields aryl hydrazine.
- Triphenyl phosphine is easy to use in commercial scale and this method is equivalent to the known method for representation of aryl hydrazine from aryl diazonium salt.
- aryl diazonium chloride is added to a solution of triphenyl phosphine (3.0 moles) in methanol (2.0 vol) at 5 to 10°C followed by water (6.0 vol) is added and maintained at room temperature for about 6 to 8 hrs. Finally to the above solution methanol (6.0 vol) Cone. HCl (6.0 vol) and water (6.0 vol) are added one after another. Heated the resulting solution to reflux temperature for 4 hrs. Cooled the reaction mass and washed with methylene chloride to remove the impurities. Distilled off methanol and water mixture under vacuum and the residue is triturated with Isopropyl alcohol to get the desired hydrazine hydrochloride with 90% yield.
- Example - J Preparation of (S)-4-(4-methylphenyl hydrazine)-!, 3-oxazolidin-2-one (S)-4-4-(amino benzyl)-l,3- oxazolidine-2-one (10 g, 0.052 moles) is suspended in water (20 ml) and cooled to -5°C. A solution of sodium Nitrite (4.2 g; 0.06 moles in 42.0 ml water) is slowly added to the above solution and stirred for 45 min. at -5 to 0 0 C.
- Example -2 Preparation of l-(4-hvdrazinophenyl) methyl-1, 2,4-traizole.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
Abstract
The present invention relates to the preparation of aryl hydrazines and their salts by treating aryl diazonium salts with triphenyl phosphine followed by hydrolysis of the resulting triphenyl-aryl hydrazyl phosphonium salt to get aryl hydrazine or its salt.
Description
"Conversion of aromatic diazonium salt to aryl hydrazine"
The present invention relates to the conversion of aromatic diazonium salt into aryl hydrazine. The aryl hydrazine thus formed can be pharmacologically useful compounds in treating a variety of ailments
Background of the invention:
Class of 5-substituted tryptamines with pharmacological activity at 5-HT ID and other monoamine receptors such as Zolmitriptan, Rizatriptan, Sumatriptan, Almotriptan, Naratriptan and Eletriptan are known for their therapeutic targets for the treatment of migraine.
ZOLMITRIPTAN (I A) RIZATRIPTAN (I B) SUMATRIPTAN (I C)
AMLOTRIPTAN (I D) NARATRIPTAN (I E) ELETRIPTAN (IF)
A common structural feature in many anti-migraine compounds is the presence of a 5- substituted indole moiety. Compounds such as Rizatriptan, Zolmitriptan, Sumatriptan, Almotriptan, Naratriptan, Eletriptan and the like, have a moiety present in their structure.
Fisher indole reaction of aryl hydrazine derivatives is well known reaction in literature. Many of the literature processes involves either isolation of that aryl hydrazine derivatives as a salt or taken directly in-situ for Fisher cyclization to give 5-substituted , tryptamines analogues. The reduction of diazonium salt to hydrazine derivative in highly acidic medium by sodium sulphite or tin chloride is well known.
U.S. Pat. No.5,399,574 describes a method for preparing Zolmitriptan and related compounds wherein the conversion of diazonium salt to hydrazine derivative is carried out in presence of tin chloride in concentrated hydrochloric acid followed by Fisher Indole cyclisation to give the desired 5-substituted tryptan. U.S. Pat. No. 5,298,520 discloses similar procedure for the synthesis of different 5-substituted tryptamines wherein the use of tin chloride is reported in presence of aqueous hydrochloric acid for the conversion of aromatic diazonium salt to hydrazine derivatives. U.S. Pat. No's. 5,567,819 and 6,084,103 also describes a process for the preparation of the Rizatriptan and related molecules wherein the conversion of aryl hydrozonium salt to hydrazine is carried out with sodium sulphite in highly acidic medium. All the above processes require tin chloride as a reducing agent which is not easy to remove from the reaction mixture and is required more equivalents for reaction completion. The above processes make the finished product expensive. Isolation of the product from such reaction mixture is tedious, requires several critical layer separations, multi step column chromatography which ultimately gives low yield of the product.
Surprisingly the present inventors have found that by using two moles of triphenyl phosphine for the conversion of diazonium salt to hydrazine derivative is a superior alternative to the existing tin chloride or sodium sulphite process.
Summary of the invention:
In one aspect the present invention is provided a process for the conversion of an aryl diazonium salt of formula- II wherein R is selected from A,B,C,D,F and their substituted derivatives to aryl hydrazine of formula - III,
D FORMULA -III
Wherein R is defined as above and X is a salt or a protecting group with triphenyl phosphine in presence of an organic solvents.
In another aspect is provided a process for the preparation Zolmitriptan structural isomer, or substituted derivative of formula - 1 A or salt thereof
FORMULA -111 A wherein R is a designated residual of formula- A, which comprises reacting in-situ intermediate of formula - II with triphenyl phosphine in methanol followed by fisher indole cyclization with N,N,dimethyl amino acetal to get Zolmitriptan isomers, substituted derivative or salt thereof.
FORMULA -Il A
Detailed description of the invention:
In accordance with the present invention aryl hydrazines of Formula -III wherein R and X are defined as above are being prepared by
• Converting the aryl amine derivatives to their diazonium salt • Treating the diazonium salt with Triphenyl phosphine to get triphenyl-aryl hydrazyl phosphonium salt
• Hydrolysis of triphenyl-aryl hydrazyl phosphonium salt to yield aryl hydrazine or its salt thereof. The reaction scheme can be expressed as follows
Scheme: 1
In a specific embodiment, the present invention provides a process for the preparation of aryl hydrazines, which involves
Dissolving the respective aryl amine in a mineral acid selected from Hydrochloric acid, Hydrobromic acid and Sulphuric acid
Cooling the solution to -15 to -1O0C
Adding the above cooled solution to a solution of sodium nitrite in a molar ratio of 1.0 to 3.0 moles preferably 1.10 to 1.20 moles dissolved in water
Maintaining the reaction mass at -15 to -50C, preferably at about -1O0C for the reaction completion to get aryl diazonium salt.
Further the obtained aryl diazonium salt is converted to aryl hydrazine derivative by,
• Adding the diazonium salt to a solution of triphenyl phosphine in a molar ratio of 2.0 to 5.0 moles preferably 3.0 moles in methanol at about 5 to 100C.
• Adding water after complete addition of triphenyl phosphine
• Stirring the reaction mass at room temperature for about 6 to 8 hrs.
• Adding methanol, Conc.HCl and water one after another to the above reaction mass.
• Heating the resulting solution to reflux temperature and maintaining for 4 hrs.
• Cooling the reaction mass and washing with water immiscible organic solvent selected from methylene chloride, chloroform, toluene, hexane, ethyl acetate etc. to remove the impurities.
• Distilling the reaction mass to remove methanol and water under vacuum to get residue
• Triturating the residue with an organic solvent to get the desired salt of aryl hydrazine derivative
However, where the intermediate aryl hydrazine salt is not isolated the crude is proceeded directly for the Fisher Indole cyclization reaction.
Triphenyl phosphine reacts with diazonium salt results a red color intermediate in a very good yield of triphenyl-aryl hydrazyl phosphonium salt, which practically disintegrate with the acidic hydrolysis quantitatively yields aryl hydrazine. Triphenyl phosphine is easy to use in commercial scale and this method is equivalent to the known method for representation of aryl hydrazine from aryl diazonium salt.
The hydrolysis of phosphonium salt with hydrochloric acid leads quantitative yield to the corresponding aryl hydrazine, which can be isolated as salt or taken in-situ to the formation of triptamine by fisher indole cyclization.
The invention is further illustrated with a few non-limiting examples
General procedure for the preparation of aryl hydrazine hydrochloride:-
A solution of respective aryl amine (1.0 mole) in cone. HCl (4.0 vol) is cooled to -15 to - 10°C and added slowly to a solution of sodium nitrite (1.10 moles) in water (4 Times). Reaction mass is maintained at -10°C for about 1 hr. for the completion of reaction to get the aryl diazonium chloride.
The obtained aryl diazonium chloride is added to a solution of triphenyl phosphine (3.0 moles) in methanol (2.0 vol) at 5 to 10°C followed by water (6.0 vol) is added and maintained at room temperature for about 6 to 8 hrs. Finally to the above solution
methanol (6.0 vol) Cone. HCl (6.0 vol) and water (6.0 vol) are added one after another. Heated the resulting solution to reflux temperature for 4 hrs. Cooled the reaction mass and washed with methylene chloride to remove the impurities. Distilled off methanol and water mixture under vacuum and the residue is triturated with Isopropyl alcohol to get the desired hydrazine hydrochloride with 90% yield.
However, where the intermediate hydrazine hydrochloride is not isolated is directly taken as such for the Fisher Indole cyclization reaction.
For example aryl hydrazine hydrochloride in Almotriptan in highly unstable and the colour immediately turns from pale yellow to dark brown. Hence, the reaction will be proceeded insitu to further step.
Example - J: Preparation of (S)-4-(4-methylphenyl hydrazine)-!, 3-oxazolidin-2-one (S)-4-4-(amino benzyl)-l,3- oxazolidine-2-one (10 g, 0.052 moles) is suspended in water (20 ml) and cooled to -5°C. A solution of sodium Nitrite (4.2 g; 0.06 moles in 42.0 ml water) is slowly added to the above solution and stirred for 45 min. at -5 to 00C.
The above reaction mixture is added lot- wise at 5°C to 10°C to a solution of Triphenyl phosphine (40.91 g; 0.155 moles) in methanol (120.0 ml) and diethyl ether (40.0 ml).The reaction mixture is stirred at room temperature for about 8hrs. After the reaction is completed the resulted dark brown oily layer is separated and evaporated under vacuum. The obtained residue is triturated with chloroform and methanol to get the desired product (35.0g).
Example -2: Preparation of l-(4-hvdrazinophenyl) methyl-1, 2,4-traizole.
4-[lH-l,2, 4-trizole-l-yl methyl] benzene amine (5.0 g;0.028 moles) is suspended in con. Hydrochloric acid (20 ml) and cooled to -15 to -10°C. A solution of sodium Nitrite (2.2 g; 0.030 moles in water 8.96 ml) is slowly added to the above solution and stirred for 60 min at about -1O0C.
The above reaction mixture is added lot-wise at 5°C to 10°C to a solution of Triphenyl phosphine (22.67 g; 0.086 moles) in methanol (44 ml) and diethyl ether (110.0 ml).The
reaction mixture is stirred at room temperature for about 8 hrs. After the reaction is completed methanol (30 ml) Cone. Hydrochloric acid (30 ml) and water (30 ml) are added to the reaction mixture and maintained the reaction mixture at reflux temperature for 5 hrs. Cooled the reaction mass to room temperature and washed the reaction mass with methylene chloride (5 x 50 ml) and distilled out methanol and water completely in vacuum. The residue is triturated with IPA (50 ml) to give the desired product as off- white solid (6.3 g).
Example-3: Preparation of 4(-j)yrrolidono sulfonyl methyl) phenyl hydrazine
4-(Pyrrolidino sulfonyl methyl) benzene amine (50.0 g; 0.022 moles) is suspended in con.
Hydrochloric acid (30 ml) and cooled to -15 to -100C. A solution of sodium Nitrite (1.97 g; 0.028 moles in water 19.85 ml) is slowly added to the above solution over 30 min and stirred for 60 min at about -100C.
The above reaction mixture is added lot- wise at 5°C to 100C to a solution of Triphenyl phosphine (17.31 g; 0.066 moles) in methanol (34.6 ml) and diethyl ether (104 ml) over 2 hrs. To the reaction mass DM water (30 ml) is added and maintained for 8 hrs at room temperature. After the reaction is completed methanol (30 ml) Cone. Hydrochloric acid (30 ml) and water (30 ml) are added to the reaction mixture and maintained the reaction mixture at reflux temperature for 5 hrs. Cooled the reaction mass to room temperature and washed the reaction mass with methylene chloride (5 x 50 ml) and distilled out methanol and water completely in vacuum. The residue is triturated with IPA (50 ml) to give the desired product as off-white solid (3.5 g).
Claims
1. A process for the preparation of aryl hydrazine of Formula -III
FORMULA -III
Wherein 'R' is selected from A, B, C, D,F and their substituted derivatives,
A B C D F
And 'X' is a salt or a protecting group, which comprises
• Dissolving the respective aryl amine in a mineral acid
• Adding the above cooled solution to a solution of sodium nitrite dissolved in water • Maintaining the reaction mass to get aryl diazonium salt
• Adding the diazonium salt to a solution of triphenyl phosphine
• Adding water after addition of triphenyl phosphine and stirring the reaction mass for the formation of triphenyl aryl hydrazyl-phosphomium salt • Hydrolysis of triphenyl aryl hydrazyl-phosphomium salt
• optionally washing the reaction mass with water immiscible organic solvent(s) to remove impurities
• isolating the aryl hydrazine as desired salt
2. The process as claimed in claim 1, wherein the mineral acid is selected from Hydrochloric acid, Hydrobromic acid and Sulphuric acid
3. The process as claimed in claim 1, wherein in the sodium nitrite is used in a molar ratio of 1.0 to 3.0 moles preferably 1.10 to 1.20 moles
4. The process as claimed in claim 1, wherein in triphenyl phosphine is used in a molar ratio of 2.0 to 5.0 moles preferably 3.0 moles
5. The process as claimed in claim 1, wherein in the water immiscible solvent is selected from methylene chloride, chloroform, toluene, hexane, ethyl acetate
6. The process as claimed in claim 1, wherein the isolation of aryl hydrazine desired salt optionally involves concentration and trituration with organic solvent(s)
7. The process as claimed in claim 1, wherein in the solvent used for trituration is selected from methanol, isopropanol, chloroform, methylene chloride and mixtures thereof
8. The process as claimed in claim 1, wherein the aryl hydrazine of the formula - III is isolated or with out isolation proceeded for further steps
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07706182A EP1981860B1 (en) | 2006-01-19 | 2007-01-12 | Conversion of aromatic diazonium salt to aryl hydrazine |
US12/160,669 US20110313171A1 (en) | 2006-01-19 | 2007-01-12 | Conversion of aromatic diazonium salt to aryl hydrazine |
AT07706182T ATE510836T1 (en) | 2006-01-19 | 2007-01-12 | CONVERSION OF AN AROMATIC DIAZONIUM SALT INTO AN ARYLHYDRAZINE |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN90/CHE/2006 | 2006-01-19 | ||
IN90CH2006 | 2006-01-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007083320A2 true WO2007083320A2 (en) | 2007-07-26 |
WO2007083320A3 WO2007083320A3 (en) | 2009-06-11 |
Family
ID=38288020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2007/000011 WO2007083320A2 (en) | 2006-01-19 | 2007-01-12 | Conversion of aromatic diazonium salt to aryl hydrazine |
Country Status (4)
Country | Link |
---|---|
US (1) | US20110313171A1 (en) |
EP (1) | EP1981860B1 (en) |
AT (1) | ATE510836T1 (en) |
WO (1) | WO2007083320A2 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010535187A (en) * | 2007-08-02 | 2010-11-18 | ジェネリクス・(ユーケー)・リミテッド | New method |
WO2012102404A1 (en) | 2011-01-30 | 2012-08-02 | Meiji Seikaファルマ株式会社 | Topical antifungal agent |
WO2014021282A1 (en) | 2012-07-30 | 2014-02-06 | Meiji Seikaファルマ株式会社 | Antitrichophytosis solution for external use |
WO2014021284A1 (en) | 2012-07-30 | 2014-02-06 | Meiji Seikaファルマ株式会社 | Anti-trichophytic adhesive patch |
CN106397359A (en) * | 2016-08-31 | 2017-02-15 | 重庆华森制药股份有限公司 | Preparation method of almotriptan intermediate 4-(1-pyrrolidyl sulfomethyl)-phenylhydrazine |
CN115353492A (en) * | 2022-08-26 | 2022-11-18 | 浙江野风药业股份有限公司 | Method for continuously synthesizing 1- (4-hydrazinophenyl) methyl-1, 2,4-triazole |
US11649213B2 (en) | 2018-09-26 | 2023-05-16 | Mereo Biopharma 1 Limited | Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5298520A (en) | 1991-02-01 | 1994-03-29 | Merck Sharp & Dohme Limited | Triazole containing indole derivatives |
US5399574A (en) | 1990-06-07 | 1995-03-21 | Burroughs Wellcome Co. | Indolyl tetrahydropyridines for treating migraine |
US5567819A (en) | 1992-07-22 | 1996-10-22 | Merck, Sharp & Dohme, Ltd. | Process for preparing indole derivatives containing a 1,2,4-triazol-1-yl substituent |
US6084103A (en) | 1995-08-07 | 2000-07-04 | Zeneca Limited | One pot synthesis of 2-oxazolidinone derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5567824A (en) * | 1994-05-24 | 1996-10-22 | Merck & Co., Inc. | Palladium catalyzed ring closure of triazolyltryptamine |
ES2204303B2 (en) * | 2002-08-07 | 2004-12-16 | Laboratorios Vita, S.A. | PROCEDURE FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND. |
ES2204302B2 (en) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | PROCEDURE FOR OBTAINING A PHARMACEUTICALLY ACTIVE COMPOUND. |
-
2007
- 2007-01-12 AT AT07706182T patent/ATE510836T1/en not_active IP Right Cessation
- 2007-01-12 WO PCT/IN2007/000011 patent/WO2007083320A2/en active Application Filing
- 2007-01-12 US US12/160,669 patent/US20110313171A1/en not_active Abandoned
- 2007-01-12 EP EP07706182A patent/EP1981860B1/en not_active Not-in-force
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399574A (en) | 1990-06-07 | 1995-03-21 | Burroughs Wellcome Co. | Indolyl tetrahydropyridines for treating migraine |
US5298520A (en) | 1991-02-01 | 1994-03-29 | Merck Sharp & Dohme Limited | Triazole containing indole derivatives |
US5567819A (en) | 1992-07-22 | 1996-10-22 | Merck, Sharp & Dohme, Ltd. | Process for preparing indole derivatives containing a 1,2,4-triazol-1-yl substituent |
US6084103A (en) | 1995-08-07 | 2000-07-04 | Zeneca Limited | One pot synthesis of 2-oxazolidinone derivatives |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010535187A (en) * | 2007-08-02 | 2010-11-18 | ジェネリクス・(ユーケー)・リミテッド | New method |
WO2012102404A1 (en) | 2011-01-30 | 2012-08-02 | Meiji Seikaファルマ株式会社 | Topical antifungal agent |
WO2014021282A1 (en) | 2012-07-30 | 2014-02-06 | Meiji Seikaファルマ株式会社 | Antitrichophytosis solution for external use |
WO2014021284A1 (en) | 2012-07-30 | 2014-02-06 | Meiji Seikaファルマ株式会社 | Anti-trichophytic adhesive patch |
CN106397359A (en) * | 2016-08-31 | 2017-02-15 | 重庆华森制药股份有限公司 | Preparation method of almotriptan intermediate 4-(1-pyrrolidyl sulfomethyl)-phenylhydrazine |
CN106397359B (en) * | 2016-08-31 | 2017-12-05 | 重庆华森制药股份有限公司 | The preparation method of almotriptan intermediate 4 (1 pyrrolidinyl sulfonymethyl) phenylhydrazine |
US11649213B2 (en) | 2018-09-26 | 2023-05-16 | Mereo Biopharma 1 Limited | Synthetic method for the preparation of a 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol compound |
CN115353492A (en) * | 2022-08-26 | 2022-11-18 | 浙江野风药业股份有限公司 | Method for continuously synthesizing 1- (4-hydrazinophenyl) methyl-1, 2,4-triazole |
Also Published As
Publication number | Publication date |
---|---|
US20110313171A1 (en) | 2011-12-22 |
ATE510836T1 (en) | 2011-06-15 |
EP1981860B1 (en) | 2011-05-25 |
WO2007083320A3 (en) | 2009-06-11 |
EP1981860A2 (en) | 2008-10-22 |
EP1981860A4 (en) | 2010-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1981860B1 (en) | Conversion of aromatic diazonium salt to aryl hydrazine | |
EP1465880B1 (en) | 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine | |
FI110779B (en) | Process for the preparation of indole derivatives containing 1,2,4-triazol-1-yl substituent | |
JP2010535187A (en) | New method | |
JP2846042B2 (en) | Method for producing indolecarboxylic acid derivative | |
CA2047880A1 (en) | Benzimidazole derivatives, their preparation and pharmacological applications | |
JPH0570443A (en) | Process for producing 2-(2',4'-dihydroxyphenyl)-4,6- diaryl-s-triazine | |
US6407255B2 (en) | Chemical synthesis of 1,2,4-triazolinone derivative | |
JPS6216460A (en) | Novel derivative of indolecarboxyamide, salt of same, manufacture, use as intermediate and drug and composition containing same | |
CH671017A5 (en) | ||
US6388091B1 (en) | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one | |
JP3285581B2 (en) | Imidazole, triazole and tetrazole derivatives | |
KR910009200B1 (en) | Proces for preparing azole type dioxolane derivatives | |
US20110112157A1 (en) | Process for the preparation of zolmitriptan, salts and solvates thereof | |
FR2510110A1 (en) | ||
US6673939B2 (en) | Process for the preparation of 1,2,4-triazolin-5-one derivatives | |
US4864032A (en) | Process for the preparation of indazoles | |
EP2751098B1 (en) | An improved process for preparation of zolmitriptan | |
Connor et al. | Synthesis of the 3a, 8a-dihydrofuro [2, 3-b] benzofuran-2 (3H)-one and 1, 3, 3a, 8a-tetrahydro-2H-benzofuro [2, 3-b] pyrrol-2-one ring systems from 4-formylcoumarin via acyllactone and iminolactone rearrangements | |
SE443560B (en) | ANALOGY PROCEDURE FOR PREPARATION OF 1-AMINO-LOWER ALKYL-3,4-DIPHENYL-1H-PYRAZOLES | |
EP0083566A1 (en) | Isoxazolyl indoles | |
RU2207340C2 (en) | Method for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazole-4-one or its pharmaceutically acceptable salts | |
NO884362L (en) | Isoxazolidin-DERIVATIVES. | |
US4777263A (en) | 5-substituted-3-(2-naphthalenyl)-3-((1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl))-2-methylisoxazolidines | |
JP4611026B2 (en) | A novel process for the preparation of imidazolyl compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007706182 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12160669 Country of ref document: US |